Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECORD-4: Everolimus in mRCC
NCT01491672Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2011
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of everolimus in metastatic renal cell carcinoma (mRCC), sponsored by Novartis. Started Nov 2011; status: completed.
02
Drugs
everolimus
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT01491672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01491672.